News – Page 7 – Endpoints News

Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff

2 weeks ago

Intellia reports case of liver toxicity in ATTR gene editing study

2 weeks ago

Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+ revenue milestone

2 weeks ago

DNA giant Illumina spawned an ecosystem of competitors and customers

2 weeks ago

Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss

2 weeks ago

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

2 weeks ago

Oric locks down cash for Phase 3 prostate cancer trial with early data in hand

2 weeks ago

PepGen ditches Duchenne programs after mid-stage fail, switches to previously halted muscle wasting therapy

2 weeks ago

Exclusive: Movement disorder biotech Vima steps onto scene with $60M

2 weeks ago

Updated: Trump administration halts more than $750M in funds for Moderna’s bird flu vaccine

3 weeks ago

The fate of Moderna’s next-gen Covid shot looms large after a flurry of policy changes

3 weeks ago

Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

3 weeks ago

Insurance startup Devoted Health cuts 5% of workers in small layoff

3 weeks ago

GSK, Spero report Phase 3 win for UTI antibiotic; Spero's stock soars

3 weeks ago

Weeks after TIGIT fail, iTeos decides to wind down

3 weeks ago

Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight

3 weeks ago

A new dawn for psychedelics? Compass could be the first to find out

3 weeks ago

Post-Hoc Live: Is biotech sentiment really as bad as it seems?

3 weeks ago

Strand Therapeutics reports promising start for mRNA cancer therapy

3 weeks ago

Updated: MD Anderson-allied investment firm targets $250M for second cancer biotech fund

3 weeks ago

InflaRx cans Gohibic development after skin disease trial stopped for futility

3 weeks ago

Axsome and Hetero settle patent fight over sleep disorder drug

3 weeks ago

Novartis won bidding war for kidney drug as Regulus' top three execs expect to make over $100M combined

3 weeks ago

FDA leadership preps for summer biopharma listening tour across six cities

3 weeks ago

First page Previous page 4 5 678 9 10 Next page Last page